Application of next-generation sequencing in gastrointestinal and liver tumors
-
Published:2016-05
Issue:2
Volume:374
Page:187-191
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Mikhail SamehORCID,
Faltas Bishoy,
Salem Mohamed E.,
Bekaii-Saab Tanios
Subject
Cancer Research,Oncology
Reference54 articles.
1. Ten years of next-generation sequencing technology;van Dijk;Trends Genet,2014
2. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N. Engl. J. Med,2013
3. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS);Fukuoka;J. Clin. Oncol,2011
4. Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802);Zhou;Ann. Oncol,2015
5. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib;Sosman;N. Engl. J. Med,2012
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献